Digital Health in Neurology - Global Strategic Business Report

The global market for Digital Health in Neurology was estimated at US$38.4 Billion in 2024 and is projected to reach US$117.6 Billion by 2030, growing at a CAGR of 20.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Digital Health in Neurology market.

Global Digital Health in Neurology Market - Key Trends & Drivers Summarized

Can AI and Digital Biomarkers Transform Neurological Diagnosis?

The integration of artificial intelligence (AI) and digital biomarkers is revolutionizing neurological diagnosis, enabling early detection and continuous monitoring of conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. Traditional neurological diagnostics often rely on subjective assessments and in-clinic evaluations, which can lead to delayed diagnoses and inconsistent monitoring. AI-driven digital health solutions, including machine learning models analyzing brain imaging data and speech patterns, are enhancing diagnostic accuracy by detecting subtle neurological changes that may not be evident in clinical evaluations. Wearable biosensors and mobile-based cognitive assessments are further enabling remote monitoring of neurological conditions, providing real-time insights into disease progression. Additionally, AI-powered predictive analytics are being used to identify individuals at high risk of developing neurodegenerative disorders, allowing for early interventions. However, challenges such as data standardization, regulatory approvals, and AI model validation still need to be addressed. As digital biomarkers and AI-driven neurology tools continue to improve, they are expected to play a transformative role in precision medicine, offering more proactive and personalized neurological care.

How Is Tele-Neurology Expanding Access to Specialized Care?

The rapid adoption of tele-neurology is improving access to specialized neurological care, particularly in underserved and remote regions where neurologist availability is limited. Tele-neurology platforms allow patients with conditions such as stroke, epilepsy, and migraine disorders to receive expert consultations via virtual appointments, reducing the need for hospital visits and expediting treatment decisions. AI-powered decision support systems are further enhancing tele-neurology services by assisting clinicians in diagnosing neurological disorders through real-time patient data analysis. Remote EEG (electroencephalography) monitoring and mobile-based neurological assessments are also being integrated into telehealth platforms, ensuring continuous patient evaluation and timely interventions. However, tele-neurology adoption faces barriers such as reimbursement policies, data privacy concerns, and the need for advanced infrastructure in rural areas. Despite these challenges, the expansion of tele-neurology is expected to drive significant improvements in patient outcomes by making expert neurological care more accessible, cost-effective, and efficient.

Can Digital Therapeutics (DTx) Improve Neurological Disease Management?

Digital therapeutics (DTx) are emerging as a groundbreaking solution for managing neurological disorders by offering evidence-based, software-driven interventions that complement pharmacological treatments. Neurological conditions such as migraine, multiple sclerosis, and epilepsy often require long-term disease management, which can be challenging due to medication adherence issues and fluctuating symptoms. AI-driven DTx platforms provide personalized cognitive training, behavioral therapy modules, and real-time symptom tracking to improve patient adherence and overall disease management. For instance, digital cognitive training applications are being used to slow cognitive decline in Alzheimer’s patients, while digital rehabilitation programs are helping stroke survivors regain motor function. Additionally, VR-based therapies are proving effective in managing chronic pain and anxiety associated with neurological conditions. However, regulatory approvals and insurance coverage remain barriers to widespread adoption. As clinical evidence supporting DTx effectiveness continues to grow, digital therapeutics are expected to become an integral part of neurology care, improving patient engagement and long-term health outcomes.

What Is Driving the Growth of the Digital Health in Neurology Market?

The growth in the digital health in neurology market is driven by several factors, including increasing prevalence of neurological disorders, rising adoption of AI-driven diagnostics, and advancements in wearable neurology monitoring devices. The growing demand for remote patient monitoring and tele-neurology services is further accelerating market expansion, especially in regions with limited access to neurologists. The integration of digital biomarkers and predictive analytics is improving early disease detection, enabling more proactive management of neurodegenerative disorders. The expansion of digital therapeutics (DTx) for neurological conditions is also driving adoption, offering non-invasive, software-based interventions that complement traditional treatments. Additionally, regulatory support for digital health solutions and increasing investments in neurology-focused digital health startups are fueling market growth. As AI, big data, and mobile health technologies continue to evolve, digital health solutions are expected to reshape the neurology landscape, making diagnosis and treatment more accessible, efficient, and personalized.

Report Scope

The report analyzes the Digital Health in Neurology market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Component (Software Component, Hardware Component, Services); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Software Component segment, which is expected to reach US$71.6 Billion by 2030 with a CAGR of a 22.8%. The Hardware Component segment is also set to grow at 17.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $10.5 Billion in 2024, and China, forecasted to grow at an impressive 27.9% CAGR to reach $28.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Digital Health in Neurology Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Health in Neurology Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Digital Health in Neurology Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Aptar Digital Health, BrightInsight, Eli Lilly and Company, Linus Health, NeuroSync and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 34 Featured):

• Aptar Digital Health
• BrightInsight
• Eli Lilly and Company
• Linus Health
• NeuroSync
• Paradromics
• Precision Neuroscience
• Synchron
• Verana Health
• Verge Genomics
• Neuralink
• NeuroPace
• NeuroSigma
• NeuroDerm
• Neurocrine Biosciences
• NeuroMetrix
• Neurotech
• NeuroVive Pharmaceutical
• NeuroZinc

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry